TEF, HLF, BCL2L2, MAOA, SCP2, FRY, PTPRM, and CDKN1C1 were among the top associated genes for which low expression values were significantly linked to poor relapse-free survival outcomes in both the complete breast cancer dataset and the lumA subset. This evidence concerns the gene SCP2 and breast carcinoma.